Figure01 (Duloxetine Fig01)
Duloxetine Capsule, Delayed Release
Product Images NDC 71205-358
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71205-358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2 (Duloxetine Fig02)
This is a graph that represents the proportion of patients who experienced a relapse while undergoing treatment with either a placebo or duloxetine. The graph shows a decrease in the proportion of patients experiencing relapse on duloxetine compared to the placebo. The x-axis represents the time (in days) from randomization to relapse, and the y-axis shows the proportion of patients experiencing a relapse.*
Figure04 (Duloxetine Fig04)
Figure07 (Duloxetine Fig07)
The text appears to be a graph or chart with the name "Placebo" and the medication "Duloxetine" with dosages of 60/120 mg once daily. The graph has a scale from 0 to 100 with the percentage of pain improvement from baseline (BOCF) being measured. It is not possible to interpret the graph without more context or visual representation.*
Figure08 (Duloxetine Fig08)
This text appears to be a graph or chart displaying the percentage improvement in pain from baseline for a treatment involving Placebo and Duloxetine 60 mg once daily. Therefore, a useful description would be: "A graph displaying the percentage improvement in pain from baseline for Placebo treatment and Duloxetine 60 mg once daily, with improvement percentage increasing along the y-axis and medication doses increasing along the x-axis."*
Figure09 (Duloxetine Fig09)
This looks like data from a clinical trial involving the drug Duloxetine, prescribed once a day at a dosage of either 60mg or 120mg. The chart shows a scale of improvement in pain from baseline, measured in percentages. No other conclusive information can be obtained from the given text.*
Duloxetine-structure (Duloxetine Structure)
71205-358-30 (Duloxetine 60mg)
This is a medication label for Duloxetine 60mg capsules, packaged by Proficient Rx LP, located in Thousand Oaks, CA. The capsules are white with a blue color cap and imprinted with "DLX60" and "ap", packaged in a bottle with thirty capsules each. Each capsule contains 67.3mg of Duloxetine Hydrochloride USP, equivalent to 60mg Duloxetine. The medication guide for patients must be provided in each dispense. It is recommended to store the medication at 25°C and keep it out of the reach of children. The lot number is 00000 and the expiration date is 00/100/00. The product is marketed by Ajanta Pharma USA Inc. in Bridgewater, NJ and has been made in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
